Advertisement

Analytical and Bioanalytical Chemistry

, Volume 411, Issue 27, pp 7293–7301 | Cite as

Visual and spectrophotometric detection of metformin based on the host-guest molecular recognition of cucurbit[6]uril-modified silver nanoparticles

  • Zhaorui Song
  • Lili Yu
  • Yiyang Sun
  • Hua HeEmail author
Research Paper
  • 122 Downloads

Abstract

A simple, sensitive, and naked-eye assay of metformin (MET), based on the host–guest molecular recognition of cucurbit[6]uril (CB[6])-modified silver nanoparticles, has been developed for the first time. The molecular recognition between CB[6] and MET is initially demonstrated and the related recognition mechanism is further discussed. CB[6]-modified AgNPs were first synthesized and then characterized by UV–vis spectroscopy, Fourier transform infrared spectroscopy, and transmission electron microscopy. The solution behavior of CB[6] in the presence of AgNO3 was also studied, and the correlative result revealed that AgNPs could combine with the carbonyl portals of CB[6]. On the basis of the molecular recognition of CB[6] and the surface plasmon resonance effect of AgNPs, CB[6]-modified AgNPs were used as visual probes to detect MET. In CB[6]-modified AgNP solution, the aggregation of CB[6]-modified AgNPs induced by MET triggered changes of color and the UV–vis absorption spectrum, which laid the foundation for the visual identification and spectrophotometric determination of MET. Under the optimized detection conditions, the UV–vis spectral assay had a good linear relationship in the range from 3 to 750 μM, and the limit of detection was 1 μM. According to the color changes, the minimum concentration recognized by the naked eye was about 75 μM. Furthermore, this assay has high selectivity for coexisting interferents and was also applied to MET detection in human urine samples. This strategy provides a novel and facile tool for highly selective and sensitive detection of MET.

Graphical abstract

Keywords

Metformin Cucurbit[6]uril Silver nanoparticles Host–guest recognition Visual probes Spectrophotometric analysis 

Notes

Acknowledgements

This work was financially supported by the Independent Innovation Fund Project of Agricultural Science and Technology of Jiangsu Province in 2017 (no. CX(17)1003), the Guizhou Provincial Science and Technology Department Joint Fund Project (Qian Kehe LH word [2016] no. 7076), and the project funded by the Research Protection Department of Jiangsu Province (grant no. 2015026).

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no competing interests.

Supplementary material

216_2019_2105_MOESM1_ESM.pdf (1.1 mb)
ESM 1 (PDF 1.09 mb)

References

  1. 1.
    Ibáñez M, Gracia-Lor E, Bijlsma L, Morales E, Pastor L, Hernández F. Removal of emerging contaminants in sewage water subjected to advanced oxidation with ozone. J Hazard Mater. 2013;260:389–98.PubMedGoogle Scholar
  2. 2.
    Gholivand MB, Shamsipour M, Paimard G, Feyzi M, Jafari F. Synthesis of Fe-Cu/TiO2 nanostructure and its use in construction of a sensitive and selective sensor for metformin determination. Mater Sci Eng. 2014;42:791–8.Google Scholar
  3. 3.
    Grzybowska M, Bober J, Olszewska M. Metformin-mechanisms of action and use for the treatment of type 2 diabetes mellitus. Postepy Hig Med Dosw. 2011;6:277–85.Google Scholar
  4. 4.
    Li DH, Yeung SCJ, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009;137:482–8.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Donnana K, Segar L. SGLT2 inhibitors and metformin: dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. Eur J Pharmacol. 2019;846:23–9.Google Scholar
  6. 6.
    Dissanayake AM, Wheldon MC, Hood CJ. Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes. Pharmacol Res Perspect. 2018;6:1–12.Google Scholar
  7. 7.
    Liu Y, Huang LJ, Wang JD, Ding CR, Xu SR, Feng S, et al. Simultaneous determination of three diabetic drugs in urine by high performance liquid chromatography. J Instrum Anal. 2011;30:293–7.Google Scholar
  8. 8.
    Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab. 2005;7:654–65.PubMedGoogle Scholar
  9. 9.
    Stevens A, Hamel JF, Toure A, Hadjadj S, Boels D. Metformin overdose: a serious iatrogenic complication—Western France Poison Control Centre data analysis. Basic Clin Pharmacol Toxicol. 2019.  https://doi.org/10.1111/bcpt.13273.Google Scholar
  10. 10.
    Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50:81–98.PubMedGoogle Scholar
  11. 11.
    Yang HJ, Zhang HB, Xu R, Gao HG, Yuan Y, Zhao J. Determination of metformin hydrochloride tablets in healthy plasma and urine by ion exchange chromatography. Chin J Clin Pharmacol. 2017;33:821–4.Google Scholar
  12. 12.
    Ayoub BM. UPLC simultaneous determination of empagliflozin, linagliptin and metformin. RSC Adv. 2015;5:95703–9.Google Scholar
  13. 13.
    Cheng CL, Chou CH. Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection. J Chromatogr B. 2001;762:51–8.Google Scholar
  14. 14.
    Moussa BA, Mahrouse MA, Fawzy MG. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: application to a pharmacokinetic study in healthy volunteers. J Pharmaceut Biomed. 2019;163:153–61.Google Scholar
  15. 15.
    Strugaru AM, Kazakova J, Butnaru E, Caba LC, Bello-López MA, Fernández-Torres R. Simultaneous determination of metformin and glimepiride in human serum by ultra-high performance liquid chromatography quadrupole time of flight mass spectrometry detection. J Pharmaceut Bio Med. 2019;165:276–83.Google Scholar
  16. 16.
    Shah PA, Shrivastav PS. Ion-pair solid phase extraction for the simultaneous separation and quantitation of metformin and canagliflozin in human plasma by LC-MS/MS. Microchem J. 2018;143:181–9.Google Scholar
  17. 17.
    Mahgoub H, Youssef RM, Korany MA, Khamis EF, Kamal MF. Development and validation of spectrophotometric and HPTLC methods for simultaneous determination of rosiglitazone maleate and metformin hydrochloride in the presence of interfering matrix excipients. Drug Dev Ind Pharm. 2014;40:1190–8.PubMedGoogle Scholar
  18. 18.
    Song JL, Chen HF, Tian SJ, Sun ZP. Determination of metformin in plasma by capillary electrophoresis using field-amplified sample stacking technique. J Chromatogr B. 1998;708:277–83.Google Scholar
  19. 19.
    Mirzajani R, Karimi S. Preparation of γ-Fe2O3/hydroxyapatite/Cu(II) magnetic nanocomposite and its application for electrochemical detection of metformin in urine and pharmaceutical samples. Sens Actuators B. 2018;270:405–16.Google Scholar
  20. 20.
    Makwana BA, Darjee S, Jain VK, Kongor A, Sindhav G, Rao MV. A comparative study: metal nanoparticles as fluorescent sensors for biomolecules and their biomedical application. Sens Actuators B. 2017;246:686–95.Google Scholar
  21. 21.
    Wen D, Liu W, Herrmann AK, Haubold D, Holzschuh M, Simon F, et al. Simple and sensitive colorimetric detection of dopamine based on assembly of cyclodextrin-modified Au nanoparticles. Small. 2016;12:2439–42.PubMedGoogle Scholar
  22. 22.
    Rajamanikandan R, Ilanchelian M. Simple and visual approach for highly selective biosensing of vitamin B1 based on glutathione coated silver nanoparticles as a colorimetric probe. Sens Actuators B. 2016;244:380–6.Google Scholar
  23. 23.
    Pelle FD, Scroccarello A, Scarano S, Compagnone D. Silver nanoparticles based plasmonic assay for the determination of sugar content in food matrices. Anal Chem Acta. 2019;1051:129–37.Google Scholar
  24. 24.
    Huang SX, Jin YN, Cao GM, Tian YF, Xu KL, Hou XD. A silver nanoparticle-based colorimetric assay of trace selenium with hydride generation for sample introduction. Microchem J. 2018;141:258–63.Google Scholar
  25. 25.
    Quinten M. The color of finely dispersed nanoparticles. Appl Phys B. 2001;73:317–26.Google Scholar
  26. 26.
    Liu CW, Lian JY, Liu Q, Xu CL, Li BX. β-Cyclodextrin-modified silver nanoparticles as colorimetric probes for the direct visual enantioselective recognition of aromatic a-amino acids. Anal Methods. 2016;8:5794–880.Google Scholar
  27. 27.
    Zhang L, Xu CL, Liu CW, Li BX. Visual chiral recognition of tryptophan enantiomers using unmodified gold nanoparticles as colorimetric probes. Anal Chem Acta. 2014;809:123–7.Google Scholar
  28. 28.
    Sutariya PG, Pandya A, Lodha A, Menon SK. A simple and rapid creatinine sensing via DLS selectivity using calix[4]arene thiol functionalized gold nanoparticles. Talanta. 2016;147:590–7.PubMedGoogle Scholar
  29. 29.
    Yao Y, Zhou YJ, Dai J, Yue SY, Xue M. Host-guest recognition-induced color change of water-soluble pillar[5]arene modified silver nanoparticles for visual detection of spermine analogues. Chem Commum. 2014;50:869–71.Google Scholar
  30. 30.
    Zou F, Wu BP, Wang XX, Chen YY, Koh K, Wang KM, et al. Signal amplification and dual recognition strategy for small-molecule detection by surface plasmon resonance based on calix[4]arene crown ether-modified gold nanoparticles. Sens Actuators B. 2017;241:160–7.Google Scholar
  31. 31.
    Han CP, Zeng LL, Li HB, Xie GY. Colorimetric detection of pollutant aromatic amines isomers with p-sulfonatocalix[6]arene-modified gold nanoparticles. Sens Actuators B. 2009;137:704–9.Google Scholar
  32. 32.
    Xiong DJ, Chen ML, Li HB. Synthesis of para-sulfonatocalix[4]arene modified silver nanoparticles as colorimetric histidine probes. Chem Commun. 2008:880–2.Google Scholar
  33. 33.
    Li H, Chen DX, Sun YL, Zheng YB, Tan LL, Weiss PS, et al. Viologen-mediated assembly of and sensing with carboxylatopillar[5]arene-modified gold nanoparticles. J Am Chem Soc. 2013;135:1570–6.PubMedGoogle Scholar
  34. 34.
    Kim HJ, Lee MH, Mutihac L, Vicens J, Kim JS. Host-guest sensing by calixarenes on the surfaces. Chem Soc Rev. 2012;41:1173–90.PubMedGoogle Scholar
  35. 35.
    Kuang H, Chen W, Yan WJ, Xu LG, Zhu YY, Chu HQ, et al. Crown ether assembly of gold nanoparticles: melamine sensor. Biosens Bioelectron. 2011;26:2032–7.PubMedGoogle Scholar
  36. 36.
    Wei LM, Wang XY, Li C, Li XX, Yin YM, Li GX. Colorimetric assay for protein detection based on “nano-pumpkin” induced aggregation of peptide-decorated gold nanoparticles. Biosens Bioelectron. 2015;71:348–52.PubMedGoogle Scholar
  37. 37.
    Xiao H, Liu L, Meng FB, Huang JY, Li GX. Electrochemical approach to detect apoptosis. Anal Chem. 2008;8:5272–5.Google Scholar
  38. 38.
    Lanterna A, Pino E, Doménech-Carbó A, González-Béjar M, Pérez-Prieto J. Enhanced catalytic electrochemical reduction of dissolved oxygen with ultraclean cucurbituril[7]-capped gold nanoparticles. Nanoscale. 2014;6:9550–3.PubMedGoogle Scholar
  39. 39.
    Ding XR, Li H, Xie HN, Huang Y, Hou YF, Yin YM. A novel method to assay molecular chaperone activity of HSP70: evaluation of drug resistance in cancer treatment. Biosens Bioelectron. 2013;15:75–9.Google Scholar
  40. 40.
    Mock WL, Shih NY. Organic ligand-receptor interactions between cucurbituril and alkylammonium ions. J Am Chem Soc. 1988;110:4706–10.Google Scholar
  41. 41.
    Mock WL, Shih NY. Structure and selectivity in host-guest complexes of cucurbituril. J Org Chem. 1986;51:4440–6.Google Scholar
  42. 42.
    Mock WL, Pierpont J. A cucurbituril-based molecular switch. Chem Commun. 1990:1509–11.Google Scholar
  43. 43.
    Pozo MD, Casero E, Quintana C. Visual and spectrophotometric determination of cadaverine based on the use of gold nanoparticles capped with cucurbiturils or cyclodextrins. Microchim Acta. 2017;184:2107–14.Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Analytical ChemistryChina Pharmaceutical UniversityNanjingChina
  2. 2.Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of EducationChina Pharmaceutical UniversityNanjingChina
  3. 3.Key Laboratory of Biomedical Functional MaterialsChina Pharmaceutical UniversityNanjingChina

Personalised recommendations